ArticleCardiovascular and interventional radiology2026
Risk Factors for Target Vessel Re-intervention After Balloon Pulmonary Angioplasty in Inoperable Chronic Thromboembolic Pulmonary Hypertension.
Article in Cardiovascular and interventional radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Re-intervention After Balloon Pulmonary Angioplasty: A Staging Decision, Not a Failure.Cardiovascular and interventional radiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
purposeThis study aims to identify the risk factors of re-intervention on targeted vessels after balloon pulmonary angioplasty (BPA) in patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH). MATERIALS AND
methodsWe retrospectively analyzed consecutive patients with inoperable CTEPH undergoing BPA at a single center. Targeted vessels and patients were classified according to whether re-intervention occurred. Mixed-effects logistic regression with a patient-level random intercept was used to identify predictors of re-intervention. The optimal threshold was determined by ROC analysis. Time to re-intervention was described by vessel-level Kaplan-Meier curves, and model performance was evaluated using the C-statistic, bootstrap internal validation, calibration plots, and decision-curve analysis.
resultsWe enrolled 62 patients with inoperable CTEPH who underwent 168 BPA sessions and 412 targeted vessels. Re-intervention occurred in 98/412 vessels (23.8%) across 32/62 patients (51.6%). In mixed-effects logistic regression, percent diameter stenosis remained independently associated with re-intervention (OR = 1.38, 95% CI 1.23-1.54, p = 0.023), and pulmonary flow grade showed a strong graded association (p < 0.001). The combined model (percent diameter stenosis + pulmonary flow grade) showed good discrimination for re-intervention (AUC = 0.81, 95% CI 0.75-0.86). Kaplan-Meier curves demonstrated higher re-intervention rates in vessels with higher percent diameter stenosis and in those with pulmonary flow grade 0-1 (both log-rank p < 0.001). The combined model also had acceptable calibration and greater net benefit than percent diameter stenosis or pulmonary flow grade alone.
conclusionsBaseline pulmonary flow grade and percent diameter stenosis independently predict re-intervention after BPA. Vessels lacking high-grade flow and exhibiting greater stenosis may benefit from closer follow-up and staged dilatation strategies.
Indexed as
Identifiers
42642506What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.